174 related articles for article (PubMed ID: 35745067)
1. Properties of Parallel Tetramolecular G-Quadruplex Carrying
Clua A; Grijalvo S; Erande N; Gupta S; Yucius K; Gargallo R; Mazzini S; Manoharan M; Eritja R
Molecules; 2022 Jun; 27(12):. PubMed ID: 35745067
[TBL] [Abstract][Full Text] [Related]
2. Tuning G-Quadruplex Nanostructures with Lipids. Towards Designing Hybrid Scaffolds for Oligonucleotide Delivery.
Grijalvo S; Clua A; Eres M; Gargallo R; Eritja R
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374392
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte-specific delivery of siRNAs conjugated to novel non-nucleosidic trivalent N-acetylgalactosamine elicits robust gene silencing in vivo.
Rajeev KG; Nair JK; Jayaraman M; Charisse K; Taneja N; O'Shea J; Willoughby JL; Yucius K; Nguyen T; Shulga-Morskaya S; Milstein S; Liebow A; Querbes W; Borodovsky A; Fitzgerald K; Maier MA; Manoharan M
Chembiochem; 2015 Apr; 16(6):903-8. PubMed ID: 25786782
[TBL] [Abstract][Full Text] [Related]
4. N-Acetylgalactosamine Block-co-Polycations Form Stable Polyplexes with Plasmids and Promote Liver-Targeted Delivery.
Dhande YK; Wagh BS; Hall BC; Sprouse D; Hackett PB; Reineke TM
Biomacromolecules; 2016 Mar; 17(3):830-40. PubMed ID: 26854615
[TBL] [Abstract][Full Text] [Related]
5. Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor.
Schmidt K; Prakash TP; Donner AJ; Kinberger GA; Gaus HJ; Low A; Østergaard ME; Bell M; Swayze EE; Seth PP
Nucleic Acids Res; 2017 Mar; 45(5):2294-2306. PubMed ID: 28158620
[TBL] [Abstract][Full Text] [Related]
6. Programmed Instability of Ligand Conjugation Manifold for Efficient Hepatocyte Delivery of Therapeutic Oligonucleotides.
Terada C; Wada F; Uchida M; Yasutomi Y; Oh K; Kawamoto S; Kayaba Y; Yamayoshi A; Harada-Shiba M; Obika S; Yamamoto T
Nucleic Acid Ther; 2021 Dec; 31(6):404-416. PubMed ID: 34468210
[TBL] [Abstract][Full Text] [Related]
7. Asialoglycoprotein receptor 1 mediates productive uptake of N-acetylgalactosamine-conjugated and unconjugated phosphorothioate antisense oligonucleotides into liver hepatocytes.
Tanowitz M; Hettrick L; Revenko A; Kinberger GA; Prakash TP; Seth PP
Nucleic Acids Res; 2017 Dec; 45(21):12388-12400. PubMed ID: 29069408
[TBL] [Abstract][Full Text] [Related]
8. Identification of GalNAc-Conjugated Antisense Oligonucleotide Metabolites Using an Untargeted and Generic Approach Based on High Resolution Mass Spectrometry.
Husser C; Brink A; Zell M; Müller MB; Koller E; Schadt S
Anal Chem; 2017 Jun; 89(12):6821-6826. PubMed ID: 28520401
[TBL] [Abstract][Full Text] [Related]
9. Conjugation of mono and di-GalNAc sugars enhances the potency of antisense oligonucleotides via ASGR mediated delivery to hepatocytes.
Kinberger GA; Prakash TP; Yu J; Vasquez G; Low A; Chappell A; Schmidt K; Murray HM; Gaus H; Swayze EE; Seth PP
Bioorg Med Chem Lett; 2016 Aug; 26(15):3690-3. PubMed ID: 27268307
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Monovalent N-Acetylgalactosamine Phosphoramidite for Liver-Targeting Oligonucleotides.
Yamamoto T; Terada C; Kashiwada K; Yamayoshi A; Harada-Shiba M; Obika S
Curr Protoc Nucleic Acid Chem; 2019 Sep; 78(1):e99. PubMed ID: 31529782
[TBL] [Abstract][Full Text] [Related]
11. Serial incorporation of a monovalent GalNAc phosphoramidite unit into hepatocyte-targeting antisense oligonucleotides.
Yamamoto T; Sawamura M; Wada F; Harada-Shiba M; Obika S
Bioorg Med Chem; 2016 Jan; 24(1):26-32. PubMed ID: 26678173
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression.
Willoughby JLS; Chan A; Sehgal A; Butler JS; Nair JK; Racie T; Shulga-Morskaya S; Nguyen T; Qian K; Yucius K; Charisse K; van Berkel TJC; Manoharan M; Rajeev KG; Maier MA; Jadhav V; Zimmermann TS
Mol Ther; 2018 Jan; 26(1):105-114. PubMed ID: 28988716
[TBL] [Abstract][Full Text] [Related]
13. siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytes.
Matsuda S; Keiser K; Nair JK; Charisse K; Manoharan RM; Kretschmer P; Peng CG; V Kel'in A; Kandasamy P; Willoughby JL; Liebow A; Querbes W; Yucius K; Nguyen T; Milstein S; Maier MA; Rajeev KG; Manoharan M
ACS Chem Biol; 2015 May; 10(5):1181-7. PubMed ID: 25730476
[TBL] [Abstract][Full Text] [Related]
14. Ligands of the asialoglycoprotein receptor for targeted gene delivery, part 1: Synthesis of and binding studies with biotinylated cluster glycosides containing N-acetylgalactosamine.
Westerlind U; Westman J; Törnquist E; Smith CI; Oscarson S; Lahmann M; Norberg T
Glycoconj J; 2004; 21(5):227-41. PubMed ID: 15486455
[TBL] [Abstract][Full Text] [Related]
15. ASGPR-Mediated Uptake of Multivalent Glycoconjugates for Drug Delivery in Hepatocytes.
Monestier M; Charbonnier P; Gateau C; Cuillel M; Robert F; Lebrun C; Mintz E; Renaudet O; Delangle P
Chembiochem; 2016 Apr; 17(7):590-4. PubMed ID: 26781030
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc
Wang Y; Yu RZ; Henry S; Geary RS
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):475-485. PubMed ID: 31144994
[No Abstract] [Full Text] [Related]
17. Effect of modular conjugation strategy for
Yamamoto T; Sawamura M; Terada C; Kashiwada K; Wada F; Yamayoshi A; Obika S; Harada-Shiba M
Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):109-118. PubMed ID: 31617782
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models.
Kim Y; Jo M; Schmidt J; Luo X; Prakash TP; Zhou T; Klein S; Xiao X; Post N; Yin Z; MacLeod AR
Mol Ther; 2019 Sep; 27(9):1547-1557. PubMed ID: 31303442
[TBL] [Abstract][Full Text] [Related]
19. Asialoglycoprotein Receptor-Mediated Gene Delivery to Hepatocytes Using Galactosylated Polymers.
Thapa B; Kumar P; Zeng H; Narain R
Biomacromolecules; 2015 Sep; 16(9):3008-20. PubMed ID: 26258607
[TBL] [Abstract][Full Text] [Related]
20. Impact of Serum Proteins on the Uptake and RNAi Activity of GalNAc-Conjugated siRNAs.
Agarwal S; Allard R; Darcy J; Chigas S; Gu Y; Nguyen T; Bond S; Chong S; Wu JT; Janas MM
Nucleic Acid Ther; 2021 Aug; 31(4):309-315. PubMed ID: 33861634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
